USP Guidelines Meeting Will Hear Comments From Three Manufacturer Reps
This article was originally published in The Pink Sheet Daily
Executive Summary
Two representatives of newly merged Sanofi-Aventis and one from PhRMA are scheduled to present comments on proposed guidelines for Medicare drug formularies. AHIP will present health insurers' point of view, and PCMA will provide PBMs' response.